The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Non-Invasive Body Contouring Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Non-Invasive Body Contouring Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Non-Invasive Body Contouring Treatment in various end use industries. The expanding demands from the Postpartum Recovery, Fat Reduction and Others,, are propelling Non-Invasive Body Contouring Treatment market. Cold Treatments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sculpsure Treatments segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Invasive Body Contouring Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Invasive Body Contouring Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Invasive Body Contouring Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Invasive Body Contouring Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Invasive Body Contouring Treatment covered in this report include Cynosure, Candela, AbbVie, BTL Group of Companies, Cutera, InMode Ltd., Zerona, Lumenis and Alma Lasers, etc.
The global Non-Invasive Body Contouring Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cynosure
Candela
AbbVie
BTL Group of Companies
Cutera
InMode Ltd.
Zerona
Lumenis
Alma Lasers
Solta Medical
Lutronic Corporation
Fotona
Sciton
Global Non-Invasive Body Contouring Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Invasive Body Contouring Treatment market, Segment by Type:
Cold Treatments
Sculpsure Treatments
Injection Lipolysis Treatments
Others
Global Non-Invasive Body Contouring Treatment market, by Application
Postpartum Recovery
Fat Reduction
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Invasive Body Contouring Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Non-Invasive Body Contouring Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Non-Invasive Body Contouring Treatment in various end use industries. The expanding demands from the Postpartum Recovery, Fat Reduction and Others,, are propelling Non-Invasive Body Contouring Treatment market. Cold Treatments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sculpsure Treatments segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Invasive Body Contouring Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Invasive Body Contouring Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Invasive Body Contouring Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Invasive Body Contouring Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Invasive Body Contouring Treatment covered in this report include Cynosure, Candela, AbbVie, BTL Group of Companies, Cutera, InMode Ltd., Zerona, Lumenis and Alma Lasers, etc.
The global Non-Invasive Body Contouring Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cynosure
Candela
AbbVie
BTL Group of Companies
Cutera
InMode Ltd.
Zerona
Lumenis
Alma Lasers
Solta Medical
Lutronic Corporation
Fotona
Sciton
Global Non-Invasive Body Contouring Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Invasive Body Contouring Treatment market, Segment by Type:
Cold Treatments
Sculpsure Treatments
Injection Lipolysis Treatments
Others
Global Non-Invasive Body Contouring Treatment market, by Application
Postpartum Recovery
Fat Reduction
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Invasive Body Contouring Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Non-Invasive Body Contouring Treatment
1.1 Non-Invasive Body Contouring Treatment Market Overview
1.1.1 Non-Invasive Body Contouring Treatment Product Scope
1.1.2 Non-Invasive Body Contouring Treatment Market Status and Outlook
1.2 Global Non-Invasive Body Contouring Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Non-Invasive Body Contouring Treatment Market Size by Region (2018-2029)
1.4 Global Non-Invasive Body Contouring Treatment Historic Market Size by Region (2018-2023)
1.5 Global Non-Invasive Body Contouring Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Non-Invasive Body Contouring Treatment Market Size (2018-2029)
1.6.1 North America Non-Invasive Body Contouring Treatment Market Size (2018-2029)
1.6.2 Europe Non-Invasive Body Contouring Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Non-Invasive Body Contouring Treatment Market Size (2018-2029)
1.6.4 Latin America Non-Invasive Body Contouring Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Non-Invasive Body Contouring Treatment Market Size (2018-2029)
2 Non-Invasive Body Contouring Treatment Market by Type
2.1 Introduction
2.1.1 Cold Treatments
2.1.2 Sculpsure Treatments
2.1.3 Injection Lipolysis Treatments
2.1.4 Others
2.2 Global Non-Invasive Body Contouring Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Non-Invasive Body Contouring Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Non-Invasive Body Contouring Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Non-Invasive Body Contouring Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Non-Invasive Body Contouring Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Non-Invasive Body Contouring Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Non-Invasive Body Contouring Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Non-Invasive Body Contouring Treatment Revenue Breakdown by Type (2018-2029)
3 Non-Invasive Body Contouring Treatment Market Overview by Application
3.1 Introduction
3.1.1 Postpartum Recovery
3.1.2 Fat Reduction
3.1.3 Others
3.2 Global Non-Invasive Body Contouring Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Non-Invasive Body Contouring Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Non-Invasive Body Contouring Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Non-Invasive Body Contouring Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Non-Invasive Body Contouring Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Non-Invasive Body Contouring Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Non-Invasive Body Contouring Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Non-Invasive Body Contouring Treatment Revenue Breakdown by Application (2018-2029)
4 Non-Invasive Body Contouring Treatment Competition Analysis by Players
4.1 Global Non-Invasive Body Contouring Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Invasive Body Contouring Treatment as of 2022)
4.3 Date of Key Players Enter into Non-Invasive Body Contouring Treatment Market
4.4 Global Top Players Non-Invasive Body Contouring Treatment Headquarters and Area Served
4.5 Key Players Non-Invasive Body Contouring Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Non-Invasive Body Contouring Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cynosure
5.1.1 Cynosure Profile
5.1.2 Cynosure Main Business
5.1.3 Cynosure Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.1.4 Cynosure Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Cynosure Recent Developments
5.2 Candela
5.2.1 Candela Profile
5.2.2 Candela Main Business
5.2.3 Candela Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.2.4 Candela Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Candela Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.3.4 AbbVie Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 BTL Group of Companies Recent Developments
5.4 BTL Group of Companies
5.4.1 BTL Group of Companies Profile
5.4.2 BTL Group of Companies Main Business
5.4.3 BTL Group of Companies Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.4.4 BTL Group of Companies Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 BTL Group of Companies Recent Developments
5.5 Cutera
5.5.1 Cutera Profile
5.5.2 Cutera Main Business
5.5.3 Cutera Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.5.4 Cutera Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Cutera Recent Developments
5.6 InMode Ltd.
5.6.1 InMode Ltd. Profile
5.6.2 InMode Ltd. Main Business
5.6.3 InMode Ltd. Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.6.4 InMode Ltd. Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 InMode Ltd. Recent Developments
5.7 Zerona
5.7.1 Zerona Profile
5.7.2 Zerona Main Business
5.7.3 Zerona Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.7.4 Zerona Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Zerona Recent Developments
5.8 Lumenis
5.8.1 Lumenis Profile
5.8.2 Lumenis Main Business
5.8.3 Lumenis Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.8.4 Lumenis Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Lumenis Recent Developments
5.9 Alma Lasers
5.9.1 Alma Lasers Profile
5.9.2 Alma Lasers Main Business
5.9.3 Alma Lasers Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.9.4 Alma Lasers Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Alma Lasers Recent Developments
5.10 Solta Medical
5.10.1 Solta Medical Profile
5.10.2 Solta Medical Main Business
5.10.3 Solta Medical Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.10.4 Solta Medical Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Solta Medical Recent Developments
5.11 Lutronic Corporation
5.11.1 Lutronic Corporation Profile
5.11.2 Lutronic Corporation Main Business
5.11.3 Lutronic Corporation Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.11.4 Lutronic Corporation Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Lutronic Corporation Recent Developments
5.12 Fotona
5.12.1 Fotona Profile
5.12.2 Fotona Main Business
5.12.3 Fotona Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.12.4 Fotona Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Fotona Recent Developments
5.13 Sciton
5.13.1 Sciton Profile
5.13.2 Sciton Main Business
5.13.3 Sciton Non-Invasive Body Contouring Treatment Products, Services and Solutions
5.13.4 Sciton Non-Invasive Body Contouring Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Sciton Recent Developments
6 North America
6.1 North America Non-Invasive Body Contouring Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Non-Invasive Body Contouring Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Body Contouring Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Non-Invasive Body Contouring Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Body Contouring Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Non-Invasive Body Contouring Treatment Market Dynamics
11.1 Non-Invasive Body Contouring Treatment Industry Trends
11.2 Non-Invasive Body Contouring Treatment Market Drivers
11.3 Non-Invasive Body Contouring Treatment Market Challenges
11.4 Non-Invasive Body Contouring Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
